Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we will assume that you are happy to receive all cookies and you will not see this message again. Click 'Find out more' for information on how to change your cookie settings.

DPAG's Associate Professor Mathilda Mommersteeg and Professor Paul Riley, in collaboration with Professor Robin Choudhury from the Radcliffe Department of Medicine, will perform single cell analysis of inflammation during heart regeneration with a grant from the Chan Zuckerberg Initiative.

L-R: Prof Robin Choudhury, Prof Mathilda Mommersteeg and Prof Paul Riley

Cardiovascular disease is the leading cause of death worldwide, with a major contribution from myocardial infarction (MI), also known as a heart attack. Inflammation and ensuing fibrotic scarring on the heart are critical determinants of outcome post heart attack. 

A key, but elusive, therapeutic goal for scientists is to modulate inflammation and scarring, while enhancing normal healing. The cardiac scar that forms in the human heart after heart attack is permanent, so the heart is not able to pump as efficiently as before injury, eventually leading to heart failure. However, remarkably, some fish and neonatal mice do not scar after injury, but instead regenerate functional heart tissue. Inflammatory cells are essential for this regeneration, though their precise role is not understood. 

DPAG's Associate Professor Mathilda Mommersteeg and Professor Paul Riley, together with Professor Robin Choudhury from the Radcliffe Department of Medicine, have received funding from the Chan Zuckerberg Foundation to study the role of inflammatory cells in regenerative versus non-regenerative models post-myocardial infarction using single cell RNA sequencing (SC-Seq) and computational biology.

This grant is part of a new Initiative supporting 29 interdisciplinary teams to build a network of researchers exploring emerging ideas on the role of inflammation in disease. The teams will carry out two-year pilot projects focused on tissue-level inflammatory processes in diverse tissues and disease states.

Head of Science at the Chan Zuckerberg Initiative (CZI) Cori Bargmann said: "Knowing more about inflammation at the level of affected cells and tissues will increase our understanding of many diseases and improve our ability to cure, prevent, or manage them."

More information on the CZI and its funded projects can be found here.

Similar stories

Drug could help diabetic hearts recover after a heart attack

New research led by Associate Professor Lisa Heather has found that a drug known as molidustat, currently in clinical trials for another condition, could reduce risk of heart failure after heart attacks.

Blood bank storage can reduce ability of transfusions to treat anaemia

New research from the Swietach Group in collaboration with NHS Blood and Transplant has demonstrated that the process of storing blood in blood banks can negatively impact the function of red blood cells and consequently may reduce the effectiveness of blood transfusions, a treatment commonly used to combat anaemia.

Overlapping second messengers increase dynamic control of physiological responses

New research from the Parekh and Zaccolo groups reveals that a prototypical anchoring protein, known to be responsible for regulating several important physiological processes, also orchestrates the formation of two important universal second messengers.

Xin Sun shortlisted in national science image competition

DPAG Postdoctoral Research Scientist Dr Xin Sun has been shortlisted in the British Heart Foundation’s (BHF) annual ‘Reflections of Research’ image competition.

Feeling tired? Here’s how the brain’s ‘hourglass’ controls your need for sleep – new research

New article on The Conversation website written by Dr Lukas Krone, Associate Professor Vladyslav Vyazovskiy and Professor Zoltán Molnár.